Abstract Details
| Michael C. Levin, MD, FAAN (University of Saskatchewan) | Dr. Levin has received personal compensation for serving as an employee of Merck. Dr. Levin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Levin has received research support from CIHR. |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Nicholas Gavin | No disclosure on file |